Literature DB >> 19013149

The role of protease activity in ErbB biology.

Carl P Blobel1, Graham Carpenter, Matthew Freeman.   

Abstract

Proteases are now recognized as having an active role in a variety of processes aside from their recognized metabolic role in protein degradation. Within the ErbB system of ligands and receptors, proteases are known to be necessary for the generation of soluble ligands from transmembrane precursors and for the processing of the ErbB4 receptor, such that its intracellular domain is translocated to the nucleus. There are two protease activities involved in the events: proteases that cleave within the ectodomain of ligand (or receptor) and proteases that cleave the substrate within the transmembrane domain. The former are the ADAM proteases and the latter are the gamma-secretase complex and the rhomboid proteases. This review discusses the roles of each of these protease systems within the ErbB system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013149      PMCID: PMC2646910          DOI: 10.1016/j.yexcr.2008.10.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  135 in total

1.  Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila.

Authors:  J R Lee; S Urban; C F Garvey; M Freeman
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

2.  Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage.

Authors:  Chang-Yuan Ni; Hongping Yuan; Graham Carpenter
Journal:  J Biol Chem       Date:  2002-11-25       Impact factor: 5.157

Review 3.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions.

Authors:  Darren F Seals; Sara A Courtneidge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

4.  Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55.

Authors:  A Kuo; C Zhong; W S Lane; R Derynck
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

5.  Intracellular trafficking by Star regulates cleavage of the Drosophila EGF receptor ligand Spitz.

Authors:  Rachel Tsruya; Ayelet Schlesinger; Aderet Reich; Limor Gabay; Amir Sapir; Ben-Zion Shilo
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

Review 6.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

7.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases.

Authors:  S Urban; J R Lee; M Freeman
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

9.  TACE is required for the activation of the EGFR by TGF-alpha in tumors.

Authors:  Maria Borrell-Pagès; Federico Rojo; Joan Albanell; Josep Baselga; Joaquín Arribas
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

10.  Mechanism of activation of the Drosophila EGF Receptor by the TGFalpha ligand Gurken during oogenesis.

Authors:  Christian Ghiglione; Erika A Bach; Yolande Paraiso; Kermit L Carraway; Stéphane Noselli; Norbert Perrimon
Journal:  Development       Date:  2002-01       Impact factor: 6.868

View more
  34 in total

Review 1.  E3 ubiquitin ligases in ErbB receptor quantity control.

Authors:  Kermit L Carraway
Journal:  Semin Cell Dev Biol       Date:  2010-09-22       Impact factor: 7.727

2.  Association of hOGG1 Ser326Cys polymorphism with susceptibility to hepatocellular carcinoma.

Authors:  Jun Guo; Jing Yang; Yan Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

4.  Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.

Authors:  Michelle Dang; Nicole Armbruster; Miles A Miller; Efrain Cermeno; Monika Hartmann; George W Bell; David E Root; Douglas A Lauffenburger; Harvey F Lodish; Andreas Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

Review 5.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

Review 6.  Pore-forming bacterial toxins and antimicrobial peptides as modulators of ADAM function.

Authors:  Karina Reiss; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 3.402

7.  Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.

Authors:  Monika Hartmann; Liseth M Parra; Anne Ruschel; Christina Lindner; Helen Morrison; Andreas Herrlich; Peter Herrlich
Journal:  J Biol Chem       Date:  2015-04-29       Impact factor: 5.157

8.  A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.

Authors:  Fang Yan; Liping Liu; Peter J Dempsey; Yu-Hwai Tsai; Elaine W Raines; Carole L Wilson; Hailong Cao; Zheng Cao; LinShu Liu; D Brent Polk
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

9.  iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.

Authors:  Xue Li; Thorsten Maretzky; Gisela Weskamp; Sébastien Monette; Xiaoping Qing; Priya Darshinee A Issuree; Howard C Crawford; David R McIlwain; Tak W Mak; Jane E Salmon; Carl P Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  Activation of Epidermal Growth Factor Receptor in Macrophages Mediates Feedback Inhibition of M2 Polarization and Gastrointestinal Tumor Cell Growth.

Authors:  Gang Zhao; Liping Liu; Richard M Peek; Xishan Hao; D Brent Polk; Hui Li; Fang Yan
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.